Skip to main content
Clinical Trials/NCT04502797
NCT04502797UnknownPhase 1

A Feasibility Study to Evaluate The Effect of the Electronic Patient Visit Assessment On Pain and Quality of Life for Patients With Head and Neck Cancer (HNC)

New York University1 site in 1 country30 target enrollmentStarted: October 8, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Enrollment
30
Locations
1
Primary Endpoint
Patient completion of 6 out of 7 assessments

Study Overview

Brief Summary

This randomized, non-blinded, phase 0/I study will assess the feasibility of conducting a large randomized clinical trial to evaluate the efficacy of the ePVA to improve pain management and HRQoL in HNC. Thirty participants undergoing radiation therapy (RT) (with or without chemotherapy) will be randomized to: 1) ePVA intervention or 2) usual care. The intervention consists of participants completing the ePVA every other week during radiation therapy (RT), then weeks 4, 12, and 24 after end of RT. Automated reports of ePVA data, including pain reports and patient-reports of pain medications, will be sent to providers to inform their clinical decisions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •To be eligible to participate in this study, an individual must meet all of the following criteria:
  • •Histologically diagnosed HNC
  • •Undergoing RT with or without chemotherapy,
  • •English speaking,
  • •aged 18 years or older.

Exclusion Criteria

  • •An individual who meets any of the following criteria will be excluded from participation in this study:
  • •Unable to attend scheduled appointment due to geographical, social or mental reseaons,
  • •In the opinion of the investigator, is unable or unlikely to comply fully with the study requirements or procedures for any reason (e.g. cognitve or physical impairment).

Arms & Interventions

Interventional: Electronic Patient Visit Assessment (ePVA)

Experimental

Participants diagnosed with head and neck cancer randomized to Electronic Patient Visit Assessment intervention

Intervention: Electronic Patient Visit Assessment (ePVA) (Behavioral)

Usual care

No Intervention

Participants diagnosed with head and neck cancer randomized to usual care.

Outcomes

Primary Outcomes

Patient completion of 6 out of 7 assessments

Time Frame: 24 weeks

This is defined as a binary yes/no variable as to whether a participant completed 6 out of 7 assessments.

Secondary Outcomes

  • Change in health-related quality of life(Baseline, week 4, week 12, week 24)
  • Change in pain severity(Baseline, Day 7, Day 21, Day 35)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials